The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
ESYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

4 Jul 2023 07:00

RNS Number : 8177E
essensys PLC
04 July 2023
 

4 July 2023

 

essensys plc

("ESYS" or the "Company")

 

Issue of Equity and Total Voting Rights

 

essensys plc (AIM: ESYS), the leading global provider of mission critical software-as-a-service (SaaS) and technology platforms to the flexible workspace and commercial real estate industries, confirms that, following an exercise of options by former employees, it has issued and allotted 264,402 new ordinary shares of 0.25 pence each ("Ordinary Shares").

Application has been made to the London Stock Exchange for 264,042 new Ordinary Shares to be admitted to trading on AIM. Admission and dealings in the new Ordinary Shares is expected to occur at 8.00 a.m. on 7 July 2023.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Total Voting Rights

Following Admission, the Company's total issued share capital will consist of 64,649,261 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Accordingly, the total number of voting rights in the Company is 64,649,261.

The above figure of 64,649,261 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

essensys plc

 

+44 (0)20 3102 5252

Mark Furness, Chief Executive Officer

 

 

Sarah Harvey, Chief Financial Officer

 

 

 

 

Singer Capital Markets (Nominated Adviser and Broker)

 

+44 (0)20 7496 3000

Peter Steel / Harry Gooden / George Tzimas

 

 

 

 

FTI Consulting

 

 

Jamie Ricketts / Eve Kirmatzis / Talia Shirion / Victoria Caton

 

+44 (0)20 3727 1000

 

About essensys plc

 

 

essensys is the leading global provider of software and technology for flexible, digitally-enabled spaces, buildings and portfolios. The essensys Platform simplifies and automates the delivery and management of next generation, flexible, multi-tenant real estate.

The real estate industry is transforming - it must be flexible to changing market demands, accommodate hybrid working styles, provide move-in ready spaces and deliver frictionless experiences and on-demand services. The office sector is becoming an increasingly digital-first landscape - driven by end-user demand and delivering digitally enabled spaces is key to success. The essensys Platform has been designed and developed to help solve the complex operational challenges faced by landlords and flexible workspace operators as they grow and scale their operations. It helps our customers to deliver a simple, secure and scalable proposition, respond to changing occupier demands, provide seamless occupier experiences, and realise smart building and ESG ambitions.

Founded in 2006 and listed on the AIM market of the London Stock Exchange since 2019, essensys is active in the UK, Europe, North America and APAC.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUOUNROAUBRAR
Date   Source Headline
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding
8th Nov 20215:54 pmRNSPosting of Annual Report and Accounts & AGM Notice
25th Oct 20215:04 pmRNSHolding(s) in Company
19th Oct 20217:00 amRNSFull Year Results
15th Oct 20217:00 amRNSNotice of Investor Meet Company Presentation
14th Oct 20217:00 amRNSCustomer Renewal
12th Oct 20219:00 amRNSNotice of Results
24th Aug 20217:00 amRNSPre-Close Trading Update
3rd Aug 20217:00 amRNSAppointment of CEO Asia Pacific
29th Jul 20211:35 pmRNSHolding(s) in Company
28th Jul 20216:15 pmRNSHolding(s) in Company
28th Jul 20216:13 pmRNSHolding(s) in Company
28th Jul 20216:12 pmRNSHolding(s) in Company
27th Jul 20218:50 amRNSDirector/PDMR Shareholding
26th Jul 202110:57 amRNSResults of General Meeting and Open Offer
9th Jul 20214:44 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
9th Jul 20217:00 amRNSResult of Placing
8th Jul 20214:35 pmRNSProposed Fundraising
4th May 202111:44 amRNSHolding(s) in Company
21st Apr 202110:07 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSDirector/PDMR Dealing
23rd Mar 20217:00 amRNSHalf-year Report
16th Mar 20212:00 pmRNSFlex Services Platform launch
10th Mar 202112:37 pmRNSNotice of Investor Meet Company Presentation
10th Mar 20217:00 amRNSNotice of Results
18th Feb 20217:00 amRNSessensys Trading Update - 18.02.2021
16th Feb 20218:28 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSAppointment of Joint Corporate Broker
24th Dec 20209:46 amRNSDirector/PDMR Shareholding
24th Nov 20205:29 pmRNSResult of AGM
4th Nov 20207:00 amRNSAppointment of CEO North America and PDMR Dealing
30th Oct 20205:27 pmRNSPosting of Annual Report and Accounts & AGM Notice
13th Oct 20203:35 pmRNSNotice of Investor Meet Company Presentation
13th Oct 20207:00 amRNSessensys plc - Full Year Results
7th Oct 20207:00 amRNSNotice of Results
24th Aug 20203:09 pmRNSHolding(s) in Company
24th Aug 202011:41 amRNSReplacement: Holding(s) in Company
24th Aug 202010:44 amRNSHolding(s) in Company
18th Aug 20207:00 amRNSTrading Statement
9th Apr 202012:17 pmRNSResult of Placing
9th Apr 20207:01 amRNSProposed placing to raise approximately £7 million
9th Apr 20207:00 amRNSHalf year results
24th Mar 20207:01 amRNSessensys - Market and trading update
18th Feb 20207:00 amRNSTrading Statement
30th Jan 20202:26 pmRNSBoard Appointments and Grant of Options
28th Nov 20191:31 pmRNSResult of Annual General Meeting
1st Nov 20194:30 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.